Authors:
Jacobsen, W
Serkova, N
Hausen, B
Morris, RE
Benet, LZ
Christians, U
Citation: W. Jacobsen et al., Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD, TRANSPLAN P, 33(1-2), 2001, pp. 514-515
Authors:
Hausen, B
Klupp, J
Christians, U
Higgins, JP
Baumgartner, RE
Hook, LE
Friedrich, S
Celnicker, A
Morris, RE
Citation: B. Hausen et al., Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys, TRANSPLANT, 72(6), 2001, pp. 1128-1137
Citation: B. Hausen et al., Viral serine proteinase inhibitor (SERP-1) effectively decreases the incidence of graft vasculopathy in heterotopic heart allografts, TRANSPLANT, 72(3), 2001, pp. 364-368
Authors:
Ikonen, TS
Gummert, JF
Hayase, M
Honda, Y
Hausen, B
Christians, U
Berry, GJ
Yock, PG
Morris, RE
Citation: Ts. Ikonen et al., Sirolimus (rapamycin) halts and reverses progression of allograft vasculardisease in non-human primates, TRANSPLANT, 70(6), 2000, pp. 969-975
Authors:
Ikonen, TS
Briffa, N
Gummert, JF
Honda, Y
Hayase, M
Hausen, B
Billingham, ME
Yock, PG
Robbins, RC
Morris, RE
Citation: Ts. Ikonen et al., Multidimensional assessment of graft vascular disease (GVD) in aortic grafts by serial intravascular ultrasound in rhesus monkeys, TRANSPLANT, 70(3), 2000, pp. 420-429
Authors:
Hausen, B
Gummert, J
Berry, GJ
Christians, U
Serkova, N
Ikonen, T
Hook, L
Legay, F
Schuler, W
Schreier, MH
Morris, RE
Citation: B. Hausen et al., Prevention of acute allograft rejection in nonhuman primate lung transplant recipients - Induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressiveactivity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin, TRANSPLANT, 69(4), 2000, pp. 488-496
Authors:
Hausen, B
Ikonen, T
Briffa, N
Berry, GJ
Christians, U
Robbins, RC
Hook, L
Serkova, N
Benet, LZ
Schuler, W
Morris, RE
Citation: B. Hausen et al., Combined immunosuppression with cyclosporine (Neoral) and SDZ RAD in non-human primate lung transplantation: Systematic pharmacokinetic-based trials to improve efficacy and tolerability, TRANSPLANT, 69(1), 2000, pp. 76-86
Authors:
Serkova, N
Hausen, B
Berry, GJ
Jacobsen, W
Benet, LZ
Morris, RE
Christians, U
Citation: N. Serkova et al., Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: Interaction with cyclosporine, J PHARM EXP, 294(1), 2000, pp. 323-332
Authors:
Serkova, N
Litt, L
Leibfritz, D
Hausen, B
Morris, RE
James, TL
Benet, LZ
Christians, U
Citation: N. Serkova et al., The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates, BR J PHARM, 129(3), 2000, pp. 485-492
Authors:
Demertzis, S
Scherer, M
Langer, F
Dwenger, A
Hausen, B
Schafers, HJ
Citation: S. Demertzis et al., Ascorbic acid for amelioration of reperfusion injury in a lung autotransplantation model in sheep, ANN THORAC, 70(5), 2000, pp. 1684-1689
Authors:
Hausen, B
Boeke, K
Berry, GJ
Christians, U
Schuler, W
Morris, RE
Citation: B. Hausen et al., Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD, ANN THORAC, 69(3), 2000, pp. 904-909
Authors:
Hausen, B
Berry, GJ
Dagum, P
Ikonen, T
Christians, U
Briffa, N
Hook, L
Morris, RE
Citation: B. Hausen et al., The histology of subcutaneously implanted donor bronchial rings correlateswith rejection scores of lung allografts in a primate lung transplant model, J HEART LUN, 18(7), 1999, pp. 714-724
Authors:
Hausen, B
Boeke, K
Berry, GJ
Segarra, IT
Christians, U
Morris, RE
Citation: B. Hausen et al., Suppression of acute rejection in allogeneic rat lung transplantation: A study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD)used alone and in combination with a microemulsion formulation of cyclosporine, J HEART LUN, 18(2), 1999, pp. 150-159
Authors:
Ikonen, TS
Gummert, JF
Honda, Y
Hayase, M
Perlroth, J
Hausen, B
Barlow, C
Fitzgerald, P
Yock, PG
Morris, RE
Citation: Ts. Ikonen et al., Development of models of graft vascular disease in nonhuman primates: Evaluation of GVD by intravascular ultrasound in a new cynomolgus model with arterial allograft exchange, TRANSPLAN P, 31(1-2), 1999, pp. 687-687
Authors:
Hausen, B
Boeke, K
Berry, GJ
Segarra, I
Benet, LZ
Christians, U
Morris, RE
Citation: B. Hausen et al., Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to ratlung allograft recipients - Potentiation of immunosuppressive efficacy andimprovement of tolerability by staggered versus simultaneous treatment, TRANSPLANT, 67(7), 1999, pp. 956-962
Authors:
Hausen, B
Boeke, K
Berry, GJ
Gummert, JF
Christians, U
Morris, RE
Citation: B. Hausen et al., Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model, TRANSPLANT, 67(3), 1999, pp. 354-359
Authors:
Segarra, I
Brazelton, TR
Guterman, N
Hausen, B
Jacobsen, W
Morris, RE
Benet, LZ
Christians, U
Citation: I. Segarra et al., Development of a high-performance liquid chromatographic electrospray massspectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin, J CHROMAT B, 720(1-2), 1998, pp. 179-187
Authors:
Gummert, JF
Ikonen, T
Briffa, N
Honda, Y
Hayase, M
Perlroth, J
Kobayashi, Y
Hausen, B
Barlow, C
Billingham, ME
Fitzgerald, P
Yock, PG
Robbins, RC
Morris, RE
Citation: Jf. Gummert et al., A new large-animal model for research of graft vascular disease, TRANSPLAN P, 30(8), 1998, pp. 4023-4023